BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34419608)

  • 1. Pharmacokinetics, plasma protein binding, and metabolism of a potential natural chemosensitizer from Marsdenia tenacissima in rats.
    Xie B; Jiang SQ; Shen XL; Wu HQ; Hu YJ
    J Ethnopharmacol; 2021 Dec; 281():114544. PubMed ID: 34419608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenacigenin B ester derivatives from Marsdenia tenacissima actively inhibited CYP3A4 and enhanced in vivo antitumor activity of paclitaxel.
    Xie B; Lu YY; Luo ZH; Qu Z; Zheng CG; Huang XA; Zhou HY; Hu YJ; Shen XL
    J Ethnopharmacol; 2019 May; 235():309-319. PubMed ID: 30772481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2.
    Wu ZL; Chen Y; Qu Z; Wu GY; He XF; Huang JW; Meng QQ; Hu YH; Shen XL; Yang RY; Hu YJ
    J Ethnopharmacol; 2022 Aug; 294():115353. PubMed ID: 35533911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distributions of eight bioactive components in rat tissues administered Marsdenia tenacissima extract orally detected through UPLC-MS/MS.
    Li S; Pei W; Guo T; Zhang H
    Biomed Chromatogr; 2021 Apr; 35(4):e5034. PubMed ID: 33226666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of eight bioactive components in Marsdenia tenacissima extract in rat plasma by LC-MS/MS and its application in a pharmacokinetic study.
    Li S; Pei WH; Zhang H
    Biomed Chromatogr; 2020 Nov; 34(11):e4946. PubMed ID: 32643816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
    Han SY; Zhao HY; Zhou N; Zhou F; Li PP
    J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C21 steroids from the stems of Marsdenia tenacissima].
    Lei YS; Li ZL; Yang SS; Liu ZL; Hua HM
    Yao Xue Xue Bao; 2008 May; 43(5):509-12. PubMed ID: 18717339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C
    Pang X; Kang LP; Fang XM; Yu HS; Han LF; Zhao Y; Zhang LX; Yu LY; Ma BP
    J Nat Med; 2018 Jan; 72(1):166-180. PubMed ID: 28914410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total aglycones from Marsdenia tenacissima increases antitumor efficacy of paclitaxel in nude mice.
    Zhu RJ; Shen XL; Dai LL; Ai XY; Tian RH; Tang R; Hu YJ
    Molecules; 2014 Sep; 19(9):13965-75. PubMed ID: 25197933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
    Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
    J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of tenacigenin B, tenacissoside H and tenacissoside I using UHPLC-ESI-Orbitrap MS/MS.
    Zhao C; Han LY; Ren W; Zhao HY; Han SY; Zheng WX; Pang LN; Li XH; Li PP
    Biomed Chromatogr; 2016 Nov; 30(11):1757-1765. PubMed ID: 27106066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of aconitine as the targeted marker of Fuzi (Aconitum carmichaeli) following single and multiple oral administrations of Fuzi extracts in rat by UPLC/MS/MS.
    Tang L; Gong Y; Lv C; Ye L; Liu L; Liu Z
    J Ethnopharmacol; 2012 Jun; 141(2):736-41. PubMed ID: 21924342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marsdenia tenacissima extract enhances gefitinib efficacy in non-small cell lung cancer xenografts.
    Han SY; Zhao W; Sun H; Zhou N; Zhou F; An G; Li PP
    Phytomedicine; 2015 May; 22(5):560-7. PubMed ID: 25981922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A UPLC-MS/MS method for in vivo and in vitro pharmacokinetic studies of psoralenoside, isopsoralenoside, psoralen and isopsoralen from Psoralea corylifolia extract.
    Wang YF; Liu YN; Xiong W; Yan DM; Zhu Y; Gao XM; Xu YT; Qi AD
    J Ethnopharmacol; 2014; 151(1):609-17. PubMed ID: 24315982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marsdenosides A-H, polyoxypregnane glycosides from Marsdenia tenacissima.
    Deng J; Liao Z; Chen D
    Phytochemistry; 2005 May; 66(9):1040-51. PubMed ID: 15896374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marsdenia tenacissima extract promotes gefitinib accumulation in tumor tissues of lung cancer xenograft mice via inhibiting ABCG2 activity.
    Zhao C; Hao H; Zhao H; Ren W; Jiao Y; An G; Sun H; Han S; Li P
    J Ethnopharmacol; 2020 Jun; 255():112770. PubMed ID: 32205262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic comparisons of benzoylmesaconine in rats using ultra-performance liquid chromatography-tandem mass spectrometry after administration of pure benzoylmesaconine and Wutou decoction.
    Dai PM; Wang Y; Ye L; Zeng S; Zheng ZJ; Li Q; Lu LL; Liu ZQ
    Molecules; 2014 Oct; 19(10):16757-69. PubMed ID: 25329869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of pharmacokinetic profiles and characteristics of active components and their metabolites in rat plasma following oral administration of the water extract of Astragali radix using UPLC-MS/MS.
    Shi J; Zheng L; Lin Z; Hou C; Liu W; Yan T; Zhu L; Wang Y; Lu L; Liu Z
    J Ethnopharmacol; 2015 Jul; 169():183-94. PubMed ID: 25917840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marsdenia tenacissima (Roxb.) Moon injection exerts a potential anti-tumor effect in prostate cancer through inhibiting ErbB2-GSK3β-HIF1α signaling axis.
    Chen X; Luo Z; Liu X; Li X; Li Q; Zhang W; Liu Y; Cheng Z; Yang X; Liu Y; Jin R; Zhu D; Wang F; Lu Q; Su Z; Guo H
    J Ethnopharmacol; 2022 Sep; 295():115381. PubMed ID: 35595220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.